期刊文献+

硼替佐米的合成工艺改进 被引量:6

Synthesis of Bortezomib
下载PDF
导出
摘要 对硼替佐米合成工艺进行优化:以异戊醛与R-(+)-苯乙胺为起始原料经缩合、加成、催化氢化和成盐得到中间体5;另外以L-苯丙氨酸为原料,经酯化、酰化及水解得中间体9;最后中间体5与中间体9经缩合、水解制得目标产物硼替佐米,总收率38.2%(以异戊醛计)。 Intermediate 5 was synthesized from 3-Methyl butanal and(R)-(+)-1-Phenylethylamine by condensation,addition,catalytic hydrogenation and salt-forming.Furthermore,intermediate 9 was synthesized from L-phenylalanine by esterification,acylation and hydrolysis.Finally,the target product,bortezomib was synthesized by condensation of intermediate 5 and intermediate 9 and hydrolysis.The overall yield was 38.2%(based on 3-methyl butanal).
出处 《药学与临床研究》 2014年第2期121-123,共3页 Pharmaceutical and Clinical Research
关键词 硼替佐米 多发性骨髓瘤 合成 Bortezomib Multip lemyeloma Synthesis
  • 相关文献

参考文献9

  • 1何东,牛挺.硼替佐米治疗多发性骨髓瘤的应用进展[J].华西医学,2012,27(2):197-202. 被引量:9
  • 2李忠,毛化,钟静芬.硼替佐米合成路线图解[J].中国医药工业杂志,2012,43(5):393-395. 被引量:9
  • 3孙江涛,孔立.一种硼替佐米的合成方法:中国,101812026[P].2010-08-25.(CA2010,153:383296)
  • 4Li YX, Plesescu M, Sheehan P. Synthesis of four iso- topically labeled forms fo a proteasome inhibitor, borte- zomib[J]. J Labelled Compd Radiopharm, 2007, 50(5- 6): 402-6.
  • 5Zhu YQ, Zhao X, Zhu XR, et al. Design, synthesis, biological evaluation, and structure-activity relationship (sar) discussion of dipeptidyl boronate proteasome in- hibitors, Part I : Comprehensive understanding of the SAR of r-amino acid boronates[J]. J Med Chem, 2009, 52(14): 4192-9.
  • 6Piekersgill IF, Bishop J, Koellner C, et al. Synthesis of boronic ester and acid compounds: WO2005097809[P]. 2005-10-20. (CA 2005, 143: 387386).
  • 7Beenen MA, An C, Ellman JA. Asymmetric coppercat- alyzed synthesis of c-amino boronate esters from N- tertbutanesulfinyl aldimines [J]. J Am Chem Soc, 2008, 130(22): 6910-1.
  • 8Venkata PR, Madinaguda MN, Hyderabad M, et al. Bortezomib and process for producing same: WO2009036281 [P]. 2009-03-19. (CA 2009, 150: 330133).
  • 9Ivanov AS, Zhalnina AA, Shishkov SV. A convergent approach to synthesis of vortezomib: the use of TBTU suppresses racemization in the fragment condensation[J]. Tetrahedron, 2009, 65(34): 7105-8.

二级参考文献62

  • 1张晓辉(综述),黄晓军(审校).造血干细胞移植治疗多发性骨髓瘤的研究进展[J].国际输血及血液学杂志,2007,30(4):328-331. 被引量:2
  • 2Kenneth CA,Melissa A,William B,et al.NCCN clinical practice guidelines in oncology multiple myeloma version I[S].2011:17.
  • 3Reeder CB,Reece DE,Kukreti V,et al.Cyclophosphamide,bortezomib and dexamethasone induction for newly diagnosed multiple myeloma:high response rates in a phaseⅡclinical trial[J].Leukemia,2009,23(7):1337-1341.
  • 4Hideshima T,Miltiades C,Akiyama M,et a1.Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341[J].Blood,2003,101(4):1530-1534.
  • 5Jullig M,Zhang WV,Ferreira A,et al.MG132induced apoptosis is associated with P53-independent induction of pro-apoptotic NOXA and transcriptional activity of beta-catenin[J].Apoptosis,2006,11(4):627-641.
  • 6Roccaro AM,Hideshima T,Raje N,et a1.Bortezomib mediates antiangi ogenesis in multiple myeloma via direct and indirect effects on endothelia1cells[J].Cancer Ras,2006,66(1):184-191.
  • 7National Comprehensive Cancer Net work(NCCN).NCCN c1inical practice guidelines in oncology TM multiple myeloma(V.3.2008).http//www.nccn.org/peofessionals/physician_gle/PDF/myeloma.pdf.
  • 8National Comprehensive Cancer Net work(NCCN).NCCN clinical practice guidelines in oncology multiple myeloma(V.1.2011).http://www.nccn.org/peofessionals/physician_gle/PDF/myeloma.pdf.
  • 9Jagannath S,Durie BG,Wolf J,et a1.Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma[J].Br J Haematol,2005,129(6):776-783.
  • 10Harousseau JL,Attal M,Leleu X,et al.Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma:results of an IFM phaseⅡstudy[J].Haematologica,2006,91(11):1498-1505.

共引文献18

同被引文献22

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部